GSK faces limited margin for error to hit 2031 sales target
RBC Capital Markets says GSK needs flawless base-business management to reach its 2031 sales target, as pipeline contributions are expected to take a few years.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.